Skip to main content
Clinical Trials/NCT06511206
NCT06511206CompletedNot Applicable

Determination of the Optimal Nutrient Mix to Acutely Increase Plasma Ketones

Maastricht University Medical Center1 site in 1 country11 target enrollmentStarted: August 8, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
11
Locations
1
Primary Endpoint
Plasma ketone levels

Study Overview

Brief Summary

This study will be performed to determine the optimal nutrient mix (predominantly based on medium-chain triglycerides (MCTs)) to induce a mild ketogenic state in healthy older (60-80y), overweight/obese (BMI: 25-35 kg/m2) individuals. Since the aim is to induce a mild ketogenic state, a 25g MCT-based nutrient mix, a 25g MCT-based nutrient mix + cofactors, or a non-ketogenic control will be compared.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
60 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Aged 60-80 years
  • •Body mass index (BMI) 25-35 kg/m2
  • •Stable dietary habits (no weight loss or gain > 5 kg in the past 3 months)
  • •Participants are able to provide signed and dated written informed consent prior to any study specific procedures

Exclusion Criteria

  • •Type 2 diabetes
  • •Pre-diabetes based on one or a combination of the following criteria:
  • •ImpairedFastingGlucose(IFG):Fasting plasma glucose ≥ 6.1mmol/l and ≤ 6.9 mmol/l.
  • •HbA1c of 5.7-6.4%.
  • •Participants with active congestive heart failure and/or severe renal and or liver insufficiency
  • •Uncontrolled hypertension
  • •Alcohol consumption of > 3 servings per day for man and > 2 servings per day for woman
  • •Unstable body weight (weight gain or loss > 5 kg in the last 3 months)
  • •Previous enrolment in a clinical study with an investigational product during the last 3 months or as judged by the investigator which would possibly hamper our study results
  • •Significant food allergies/intolerance (seriously hampering study meals)
  • •Participants who do not want to be informed about unexpected medical findings
  • •Blood donation during or within 2 months prior to the study

Arms & Interventions

non-ketogenic control

Placebo Comparator

Intervention: non-ketogenic control (Dietary Supplement)

25g MCT-based nutrient mix + cofactors

Experimental

Intervention: 25g MCT-based nutrient mix + cofactors (Dietary Supplement)

25g MCT-based nutrient mix

Experimental

Intervention: 25g MCT-based nutrient mix (Dietary Supplement)

Outcomes

Primary Outcomes

Plasma ketone levels

Time Frame: Testday 1, 2, and 3

The primary outcome is plasma ketone levels determined regularly over a defined time period after ingestion of the respective nutritional supplements, expressed as area under the curve (AUC).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials